260 related articles for article (PubMed ID: 24719843)
1. Preparation of cylinder-shaped porous sponges of poly(L-lactic acid), poly(DL-lactic-co-glycolic acid), and poly(ε-caprolactone).
He X; Kawazoe N; Chen G
Biomed Res Int; 2014; 2014():106082. PubMed ID: 24719843
[TBL] [Abstract][Full Text] [Related]
2. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration.
Widmer MS; Gupta PK; Lu L; Meszlenyi RK; Evans GR; Brandt K; Savel T; Gurlek A; Patrick CW; Mikos AG
Biomaterials; 1998 Nov; 19(21):1945-55. PubMed ID: 9863528
[TBL] [Abstract][Full Text] [Related]
3. Fabrication and characterization of six electrospun poly(alpha-hydroxy ester)-based fibrous scaffolds for tissue engineering applications.
Li WJ; Cooper JA; Mauck RL; Tuan RS
Acta Biomater; 2006 Jul; 2(4):377-85. PubMed ID: 16765878
[TBL] [Abstract][Full Text] [Related]
4. Preparation of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams by use of ice microparticulates.
Chen G; Ushida T; Tateishi T
Biomaterials; 2001 Sep; 22(18):2563-7. PubMed ID: 11516089
[TBL] [Abstract][Full Text] [Related]
5. Preparation and properties of nanosized biodegradable polymer capsules.
Sakai H; Sekita A; Tanaka K; Sakai K; Kondo T; Abe M
J Oleo Sci; 2011; 60(11):569-73. PubMed ID: 22027022
[TBL] [Abstract][Full Text] [Related]
6. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology.
Zhang R; Ma PX
J Biomed Mater Res; 1999 Mar; 44(4):446-55. PubMed ID: 10397949
[TBL] [Abstract][Full Text] [Related]
7. Polyester scaffolds with bimodal pore size distribution for tissue engineering.
Sosnowski S; Woźniak P; Lewandowska-Szumieł M
Macromol Biosci; 2006 Jun; 6(6):425-34. PubMed ID: 16761274
[TBL] [Abstract][Full Text] [Related]
8. Poly(ε-caprolactone) and poly(D,L-lactic acid-co-glycolic acid) scaffolds used in bone tissue engineering prepared by melt compression-particulate leaching method.
Barbanti SH; Santos AR; Zavaglia CA; Duek EA
J Mater Sci Mater Med; 2011 Oct; 22(10):2377-85. PubMed ID: 21833608
[TBL] [Abstract][Full Text] [Related]
9. Control of pore size and structure of tissue engineering scaffolds produced by supercritical fluid processing.
Tai H; Mather ML; Howard D; Wang W; White LJ; Crowe JA; Morgan SP; Chandra A; Williams DJ; Howdle SM; Shakesheff KM
Eur Cell Mater; 2007 Dec; 14():64-77. PubMed ID: 18085505
[TBL] [Abstract][Full Text] [Related]
10. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents.
Mooney DJ; Baldwin DF; Suh NP; Vacanti JP; Langer R
Biomaterials; 1996 Jul; 17(14):1417-22. PubMed ID: 8830969
[TBL] [Abstract][Full Text] [Related]
11. Poly(DL-lactic-co-glycolic acid) sponge hybridized with collagen microsponges and deposited apatite particulates.
Chen G; Ushida T; Tateishi T
J Biomed Mater Res; 2001 Oct; 57(1):8-14. PubMed ID: 11416843
[TBL] [Abstract][Full Text] [Related]
12. In vitro chondrocyte behavior on porous biodegradable poly(e-caprolactone)/polyglycolic acid scaffolds for articular chondrocyte adhesion and proliferation.
Jonnalagadda JB; Rivero IV; Dertien JS
J Biomater Sci Polym Ed; 2015; 26(7):401-19. PubMed ID: 25671317
[TBL] [Abstract][Full Text] [Related]
13. PCL-PGLA composite tubular scaffold preparation and biocompatibility investigation.
Mo X; Weber HJ; Ramakrishna S
Int J Artif Organs; 2006 Aug; 29(8):790-9. PubMed ID: 16969757
[TBL] [Abstract][Full Text] [Related]
14. Macroporous nanofibrous vascular scaffold with improved biodegradability and smooth muscle cells infiltration prepared by dual phase separation technique.
Wang W; Nie W; Liu D; Du H; Zhou X; Chen L; Wang H; Mo X; Li L; He C
Int J Nanomedicine; 2018; 13():7003-7018. PubMed ID: 30464455
[TBL] [Abstract][Full Text] [Related]
15. A biodegradable hybrid sponge nested with collagen microsponges.
Chen G; Ushida T; Tateishi T
J Biomed Mater Res; 2000 Aug; 51(2):273-9. PubMed ID: 10825227
[TBL] [Abstract][Full Text] [Related]
16. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the mechanical properties and cell behaviour on PLGA and PCL scaffolds for bladder tissue engineering.
Baker SC; Rohman G; Southgate J; Cameron NR
Biomaterials; 2009 Mar; 30(7):1321-8. PubMed ID: 19091399
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of three-dimensional porous scaffolds of complicated shape for tissue engineering. I. Compression molding based on flexible-rigid combined mold.
Wu L; Zhang H; Zhang J; Ding J
Tissue Eng; 2005; 11(7-8):1105-14. PubMed ID: 16144446
[TBL] [Abstract][Full Text] [Related]
19. Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration.
Thomson RC; Yaszemski MJ; Powers JM; Mikos AG
Biomaterials; 1998 Nov; 19(21):1935-43. PubMed ID: 9863527
[TBL] [Abstract][Full Text] [Related]
20. Mechanical properties and dual drug delivery application of poly(lactic-co-glycolic acid) scaffolds fabricated with a poly(β-amino ester) porogen.
Clark A; Milbrandt TA; Hilt JZ; Puleo DA
Acta Biomater; 2014 May; 10(5):2125-32. PubMed ID: 24424269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
